Skip to main content

Table 1 Schedule of assessments at baseline (0 months) and 24 months

From: Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study

Assessments

Brief description

Time-point (months)

0

24

Pre-study screening questionnaire (to determine study eligibility)

Study eligibility criteria

âś“

 

MRI safety check questionnaire

MRI eligibility

âś“

âś“

Demographic and medical history questionnaire

Questionnaire completed with the study investigator

âś“

âś“

Weight, height, waist and hip measurement

Clinical assessment

âś“

âś“

Transthoracic echocardiogram

Assess cardiac structure and function

âś“

âś“

Blood sample

Plasma electrolytes, glucose, HbA1C, lipids and urinary analyses. Blood collected for APOE genotyping and assessment of other genetic and circulating biomarkers.

âś“

âś“

Carotid intimal medial thickness

B-mode ultrasound to assess left and right internal carotid arteries and the degree of stenosis

âś“

âś“

24 h ambulatory blood pressure and ECG Holter

Simultaneous measurement of blood pressure and ECG

âś“

âś“

MRI scanning on a Siemens 3 T Skyra scanner using a 64 Channel receive only head coil.

• High resolution isotropic T1 3D MPRAGE (structural scan)

âś“

âś“

• High resolution isotropic T2 FLAIR 3D

• High resolution isotropic T2 3D

• Susceptibility-weighted image (SWI) for iron deposition

• Diffusion-weighted imaging (DWI)

• GRE field mapping

• BOLD 7 min free run (resting state connectivity)

Cognitive and mood evaluation

Validated tools for assessing mood, global cognitive ability, attention, visuospatial ability, executive function, language, memory, processing speed

âś“

âś“

Physical activity assessment

SenseWear Armband (BodyMedia FIT)

âś“

âś“